We do deals!

Some 120+ and counting with many more term sheets, giving advice or leading negotiations.  

 •Big deals - $150M upfront, $1+B total
•Early deals – discovery platforms, preclinical compounds
•Clinical stage deals – Phase 1 thru Phase 3
•Territorial deals – China, Japan, US, Europe
•Technology deals
•Company acquisitions
•Profit sharing
•Co-development, Co-promotion
•University licenses 

Takeda Fronts $46M for 2nd small molecule collaboration with BridGene

Pearl Bio signs discovery collaboration with Merck

Sibylla signs deal with Ono

Bridgene Biosciences signs deal with Galapagos​

Revir and Asieris sign deal

AbbVie and Cugene Announce Collaboration

BridGene Collaboration with Peter MacCallum Cancer Centre
​

Vaccitech acquires Avidea Technologies

https://www.bridgenebio.com/partnership" rel="noopener" target="_blank">BridGene Partners with Takeda

Evoq Therapeutics Signs Deal with Amgen
​​​​​

Aeromics & Simcere Announce Collaboration